MyFinsight
Home
About
Contact
cgem: the balance sheet
Income Statement
|
Cash Flow
|
Balance Sheet
For the quarter ending 2025-09-30, CGEM has $484,126K in assets.
Balance Sheets Overview
Assets Breakdown
Long-term investments
0
Subscribe for Financial Insights
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Quarterly
123
Balance Sheets
2025-09-30
2025-06-30
Long-term investments
139,995
242,302
Total assets
484,126
520,329
Total liabilities and stockholders' equity
484,126
520,329
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Page 1
Subscribe for Financial Insights
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Prepaid expenses and
other current assets
$9,639K
Short-term investments
$229,261K
Cash and cash
equivalents
$103,335K
Long-term investments
$139,995K
Other assets
$361K
Operating lease
right-of-use assets
$1,046K
Property and equipment,
net
$489K
Total current assets
$342,235K
Total assets
$484,126K
Total liabilities and
stockholders' equity
$484,126K
Total stockholders'
equity
$451,369K
Total liabilities
$32,757K
Total cullinan
stockholders' equity
$451,369K
Total current
liabilities
$32,757K
Accumulated deficit
-$537,406K
Accumulated other
comprehensive income (loss)
$973K
Additional paid-in capital
$987,796K
Operating lease
liabilities, current
$1,188K
Accrued expenses and
other current...
$29,847K
Accounts payable
$1,722K
Common stock, 0.0001
par value,...
$6K
Buy me a coffee
Cullinan Therapeutics, Inc. (CGEM)
Cullinan Therapeutics, Inc. (CGEM)